These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 17988261

  • 1. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F, Angele MK, Rentsch M, Graeb C, Gerbes A, Löhrs U, Beuers U, Jauch KW.
    Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
    [Abstract] [Full Text] [Related]

  • 2. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
    Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, Nery JR, Burke GW, Schiff ER, Miller J, Tzakis AG.
    Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
    [Abstract] [Full Text] [Related]

  • 3. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.
    Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
    [Abstract] [Full Text] [Related]

  • 4. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 5. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 6. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [Abstract] [Full Text] [Related]

  • 7. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study.
    Figueras J, Ibañez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, Mir J, Loinaz C, Herrera L, López-Cillero P, Santoyo J.
    Liver Transpl; 2001 Oct; 7(10):877-83. PubMed ID: 11679986
    [Abstract] [Full Text] [Related]

  • 8. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, Rosen M, Soulen M, Shaked A, Reddy KR, Olthoff KM.
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [Abstract] [Full Text] [Related]

  • 9. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.
    Lee HH, Joh JW, Park JH, Lee KW, Heo JS, Choi SH, Kim SJ, Lee SK.
    Transplant Proc; 2005 Mar; 37(2):1251-3. PubMed ID: 15848686
    [Abstract] [Full Text] [Related]

  • 10. Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma.
    Löhe F, Angele MK, Gerbes AL, Löhrs U, Jauch KW, Schauer RJ.
    Eur J Surg Oncol; 2005 Nov; 31(9):994-9. PubMed ID: 16076546
    [Abstract] [Full Text] [Related]

  • 11. Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma.
    Dudek K, Kornasiewicz O, Remiszewski P, Kobryń K, Ziarkiewicz-Wróblewska B, Górnicka B, Zieniewicz K, Krawczyk M.
    Transplant Proc; 2009 Oct; 41(8):3135-7. PubMed ID: 19857695
    [Abstract] [Full Text] [Related]

  • 12. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH, Kim DJ, Han YS, Park JB, Choi GS, Kim SJ, Joh JW, Lee SK.
    Dig Dis; 2007 Oct; 25(4):313-9. PubMed ID: 17960066
    [Abstract] [Full Text] [Related]

  • 13. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
    Zhou J, Wang Z, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY, Fan J.
    Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
    [Abstract] [Full Text] [Related]

  • 14. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Silva M, Moya A, Berenguer M, Sanjuan F, López-Andujar R, Pareja E, Torres-Quevedo R, Aguilera V, Montalva E, De Juan M, Mattos A, Prieto M, Mir J.
    Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681
    [Abstract] [Full Text] [Related]

  • 15. Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma?
    Saborido BP, Díaz JC, de Los Galanes SJ, Segurola CL, de Usera MA, Garrido MD, Elola-Olaso AM, Sánz RG, Romero CJ, Garcia García I, González EM.
    Transplant Proc; 2005 Nov; 37(9):3874-7. PubMed ID: 16386569
    [Abstract] [Full Text] [Related]

  • 16. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.
    Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK.
    Liver Transpl; 2005 Sep; 11(9):1086-92. PubMed ID: 16123959
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL, Zang YJ, Chen XG, Shen ZY.
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
    [Abstract] [Full Text] [Related]

  • 18. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
    Zhou J, Fan J, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Wang Z, Sun J, Xiao YS, He YF, Yang GH, Song K, Yuan Z, Wang YQ, Tang ZY.
    Chin Med J (Engl); 2005 Apr 20; 118(8):654-9. PubMed ID: 15899120
    [Abstract] [Full Text] [Related]

  • 19. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M.
    Ann Surg Oncol; 2008 May 20; 15(5):1375-82. PubMed ID: 18324443
    [Abstract] [Full Text] [Related]

  • 20. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Merli M, Nicolini G, Gentili F, Novelli G, Iappelli M, Casciaro G, Di Tondo U, Pecorella I, Marasco A, Onetti Muda A, Nudo F, Mennini G, Ginanni Corradini S, Riggio O, Berloco P, Attili AF, Rossi M.
    Transplant Proc; 2005 May 20; 37(6):2535-40. PubMed ID: 16182736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.